# US 6,727,264 B1 · Substituted anilinic piperidines as MCH selective antagonists

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,264 B1
- Document ID: US6727264B1
- Status: Granted
- Kind: B1
- Application number: 10/188,434
- Filed: 2002-07-03
- Granted: 2004-04-27
- Earliest claimed: 2001-07-05
- Assignees: Synaptic Pharmaceutical Corporation
- Inventors: Mohammad R. Marzabadi; John Wetzel; John E. DeLeon; Yu Jiang; Chien-An Chen; Kai Lu
- Web page: https://patentgrep.com/patent/US6727264B1

## CPC

- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 211/26: with hydrocarbon radicals, substituted by nitrogen atoms
- C07D 211/28: to which a second hetero atom is attached
- C07D 211/90: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/10: linked by a carbon chain containing aromatic rings
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 409/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D 409/14: containing three or more hetero rings
- C07D 413/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 417/10: linked by a carbon chain containing aromatic rings
- C07D 471/04: Ortho-condensed systems
- C07D 495/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therepeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

## Claims

### Claim 1

A compound having the structure:
wherein R1 is hydrogen, straight chained or branched C1-C7 alkyl, monofluoroalkyl or polyfluoroalkyl, aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more —F, —Cl, —Br, —I, —CN, —NO2, —CH3, —CF3, —COCH3, —CO2R2, phenyl, phenoxy or straight chained or branched C1-C7 alkyl;
wherein R2 is straight-chained or branched C3-C4 alkyl or cyclopropyl;
wherein R3 is aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more —F, —Cl, —Br, —I, —CN, —NO2, straight chained or branched C1-C7 alkyl;
wherein A is —H, —F, —Cl, —Br, —CN, —NO2, —COR3, —CO2R3, straight chained or branched C1-C7 alkyl, monofluoroalkyl or polyfluoroalkyl;
wherein X is O or NH; and
wherein n is an integer from 0 to 5 inclusive.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R1 is aryl optionally substituted with one or more —F, —Cl, —Br, —I, —CN, —NO2, —COCH3, —CO2R2, straight chained or branched C1-C7 alkyl;
wherein R3 is phenyl;
wherein A is H; and
wherein X is O.

### Claim 3 (depends on 2)

The compound of claim 2, wherein R2 is isopropyl.

### Claim 4 (depends on 3)

The compound of claim 3, wherein the compound has the structure:

### Claim 5 (depends on 3)

The compound of claim 3, wherein the compound has the structure:

### Claim 6 (depends on 1)

The compound of claim 1, wherein R1 is hydrogen, straight chained or branched C1-C7 alkyl; and wherein R3 is aryl.

### Claim 7 (depends on 6)

The compound of claim 6, wherein R2 is isopropyl; and A is hydrogen.

### Claim 8 (depends on 7)

The compound of claim 7, wherein the compound has the structure:

### Claim 9 (depends on 7)

The compound of claim 7, wherein the compound has the structure:

### Claim 10

A compound having the structure:
wherein W is
wherein each R1 is independently hydrogen, methyl or ethyl;
wherein R2 is straight-chained or branched C3-C4 alkyl or cyclopropyl;
wherein R3 is hydrogen, aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more —H, —F, —Cl, —Br, —I, —CN, —NO2, straight chained or branched C1-C7 alkyl;
wherein each A is independently —H, —F, —Cl, —Br, —CN, —NO2, —COR3, —CO2R3, straight chained or branched C1-C7 alkyl, monofluoroalkyl or polyfluoroalkyl;
wherein X is O, NR3, CO or may be absent; and
wherein Y is hydrogen, aryl or heteroaryl, wherein the aryl or heteroaryl is optionally substituted with one or more —F, —Cl, —Br, —I, —CN, —NO2, straight chained or branched C1-C7 alkyl.

### Claim 11 (depends on 10)

The compound of claim 10, wherein W is
and wherein X is O or may be absent.

### Claim 12 (depends on 11)

The compound of claim 11, wherein R2 is isopropyl.

### Claim 13 (depends on 12)

The compound of claim 12, wherein the compound has the structure:

### Claim 14 (depends on 12)

The compound of claim 12, wherein the compound has the structure:

### Claim 15 (depends on 10)

The compound of claim 10, wherein W is

### Claim 16 (depends on 15)

The compound of claim 15, wherein A is —H, —F, —Cl, —Br.

### Claim 17 (depends on 16)

The compound of claim 16, wherein R2 is isopropyl; and A is hydrogen.

### Claim 18 (depends on 17)

The compound of claim 17, wherein the compound has the structure:

### Claim 19 (depends on 1)

A method of reducing the body mass of a subject, which comprises administering to the subject an amount of a compound of claim 1 effective to reduce the body mass of the subject.

### Claim 20 (depends on 1)

A method of treating a subject suffering from depression, which comprises administering to the subject an amount of a compound of claim 1 effective to treat the subject's depression.
